Medtronic PLC Stock Advances 3.9%, Outperforms Peers
Dow Jones2026/10/12 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Medtronic PLC advanced 3.9% to $91.93 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,850.55 and the S&P 500 Index falling 0.1% to 7,807.24.
This was the stock's third consecutive day of gains.
Medtronic PLC closed 13.5% short of its 52-week high of $106.33, which the company achieved on November 26th.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.9% to $263.73, Danaher Corp. rose 0.6% to $221.20, and Abbott Laboratories rose 2.23% to $101.82.
Trading volume totaled 36.5 million, compared to the 50-day average of 15.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 12, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barclays (BCS.US) bets on a merger between Tesla (TSLA.US) and SpaceX (SPCX.US) in December, but prediction markets give only a 19% probability.
Barclays analyst Levy predicts that Tesla and SpaceX may merge before December to achieve AI integration. However, data from Kalshi and Polymarket indicate that the probability of a short-term merger is very low, with the market favoring such a move after 2027.
Barclays (BCS.US) bearish on Dell (DELL.US): No inflection point in AI spending, memory costs are the main reason
Barclays has downgraded Dell from Overweight to Neutral and lowered the target price. The institution noted that corporate AI spending remains low and revenue growth is driven by memory shortages, which stands in stark contrast to Michael Dell’s optimistic outlook.
Sunway Healthcare Director Khoo Chow Huat Sells 200,000 Shares
Crypto prices
More
